Search
for
Sort by
Research 961–990 of 1000+
- Benign Cutaneous Eruptions After Transplantation
- 877 Small T antigen from a folliculotropic polyomavirus activates canonical Wnt/β-catenin signaling in vivo
- 874 Chromatin architectural protein CTCF controls epidermal barrier formation, hair follicle fate maintenance and suppresses inflammatory responses in the skin epithelium
- A hedonic response to an assay made on octogenarians using cosmetics that promise to donate comfort, attractiveness and youth
- Poster Abstracts
- Nutritional Management of Menopausal Women
- Identification of neprilysin as a potential target of arteannuin using computational drug repositioning
- Abstracts from the 17th Congress of the European Society for Dermatology and Psychiatry
- A RARE CASE OF CHRONIC ACRODERMATITIS ENTEROPATHICA PERSISTING AND RECURRING IN THE ADULT AGE
- Skin Diseases (Noncancerous)
- Powder microscopy and phytochemical screening on stem bark and leaves of Buxus wallichiana Baill - Buxaceae
- Konvergentna validacija farmakoekonomskih aspekata terapije benigne hiperplazije prostate u Crnoj Gori
- Unravelling the link between insulin resistance and androgen excess
- Veterinary Pharmacology
- Les hormones sexuelles et la peau : questionnaire à l'attention des vétérinaires praticiens. Mise à jour bibliographique et synthèse
- Index
- Nociceptive and Nonnociceptive Roles of TRPV3 and Its “Druggability”
- Fatores nutricionais e resistência da haste capilar: estudo clínico piloto
- Ethnopharmacology and hair: Indian perspectives
- British Society for Dermatopathology
- Oral zinc sulphate in treatment of patients with thallium poisoning: A clinical therapeutic trial
- Risk factors for prostate cancer: a case-control study investigating selected key exposures and their interactions with predisposition genes
- Contents
- Botanical Treatment for Polycystic Ovary Syndrome
- Drugs that affect autonomic functions or the extrapyramidal system
- Menopause - Andropause - Anti-Aging 2008, 11.-13. Dezember 2008, Wien - Abstracts
- Alopecia
- NEW PROPRIETARY BRANDS: Gabapentin
- NEW PROPRIETARY BRANDS: Cephalexin
- New drugs: Agalsidase beta